Rare diseases
Investigational molecules
Locations
Back to Germany51 clinical trials in Bad Oeynhausen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
GermanyA Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
GermanyA Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus
GermanyZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
GermanyStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
GermanyStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
GermanyGermanyStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
GermanyStudy on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions
GermanyPhase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
GermanyLong‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes
GermanyA Phase 3 Study of Once‑Monthly PF‑08653944 vs Placebo for Weight Loss in Adults with Overweight or Obesity
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for heart failure and cardiovascular disease, including studies of novel compounds like baxdrostat and pelacarsen to reduce major cardiovascular events.
Advanced diagnostic approaches including PET imaging for coronary conditions.
Comprehensive research focusing on Type 2 Diabetes management and its complications, including studies on innovative treatments for diabetic peripheral neuropathy.
Novel therapeutic approaches for hypercholesterolemia and weight management.
Ground-breaking research in chronic kidney disease treatment, particularly focusing on complications associated with diabetes and hypertension.
Innovative therapies targeting kidney function preservation and disease progression.
Advanced research in hypertrophic cardiomyopathy and cardiac structural conditions, including maternal-fetal cardiac development studies.
Targeted therapies for specific cardiac conditions and preventive interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
